Microbiopharm Japan Co Ltd, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CALCITRIOL, with a corresponding US DMF Number 15128.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2018, and payment made on September 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II